thromboxanes has been researched along with Diabetic Retinopathy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harris, NR; Wright, WS | 1 |
Ibayashi, H; Umeda, F; Wasada, T; Watanabe, J | 1 |
Jansen, PD; Lahav, M; Lane, LS; Rudy, C | 1 |
Moisseiev, J; Naveh-Floman, N | 1 |
De La Cruz, JP; García Campos, J; Mérida, F; Moreno, A; Sánchez de la Cuesta, F | 1 |
Ito, H; Morita, I; Murota, S; Orimo, H; Shiraki, M; Takahashi, R | 1 |
1 review(s) available for thromboxanes and Diabetic Retinopathy
Article | Year |
---|---|
Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Retinopathy; Dinoprostone; Epoprostenol; Homeostasis; Humans; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Retina; Thromboxane A2; Thromboxanes | 1982 |
5 other study(ies) available for thromboxanes and Diabetic Retinopathy
Article | Year |
---|---|
Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina.
Topics: Animals; Arterioles; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Intraocular Pressure; Methacrylates; Mice; Mice, Inbred C57BL; Regional Blood Flow; Retinal Artery; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction; Venules | 2008 |
Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus.
Topics: Adult; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Imidazoles; Indomethacin; Male; Middle Aged; Platelet Aggregation; Quinacrine; Thromboxane B2; Thromboxanes | 1984 |
Circulating prostacyclin and thromboxane levels in patients with diabetic retinopathy.
Topics: Diabetic Retinopathy; Epoprostenol; Humans; Male; Middle Aged; Prostaglandins; Thromboxane A2; Thromboxanes | 1982 |
The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dipyridamole; Epoprostenol; Male; Mopidamol; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Pyrimidines; Rats; Rats, Wistar; Thromboxanes | 1996 |
Platelet thromboxane synthesizing activity in non-insulin-dependent diabetes: correlation with diabetic retinopathy and diabetic treatment.
Topics: Aged; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Thromboxanes | 1985 |